NL6707702A - - Google Patents

Info

Publication number
NL6707702A
NL6707702A NL6707702A NL6707702A NL6707702A NL 6707702 A NL6707702 A NL 6707702A NL 6707702 A NL6707702 A NL 6707702A NL 6707702 A NL6707702 A NL 6707702A NL 6707702 A NL6707702 A NL 6707702A
Authority
NL
Netherlands
Application number
NL6707702A
Other versions
NL159283B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6707702A publication Critical patent/NL6707702A/xx
Publication of NL159283B publication Critical patent/NL159283B/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
NL6707702.A 1966-06-08 1967-06-02 Werkwijze ter bereiding van een injecteerbaar preparaat. NL159283B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25595/66A GB1171125A (en) 1966-06-08 1966-06-08 Improvements in or relating to Injectable Preparations

Publications (2)

Publication Number Publication Date
NL6707702A true NL6707702A (nl) 1967-12-11
NL159283B NL159283B (nl) 1979-02-15

Family

ID=10230237

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6707702.A NL159283B (nl) 1966-06-08 1967-06-02 Werkwijze ter bereiding van een injecteerbaar preparaat.

Country Status (6)

Country Link
US (1) US3384544A (nl)
BE (1) BE699678A (nl)
FR (1) FR7316M (nl)
GB (1) GB1171125A (nl)
IT (1) IT1035004B (nl)
NL (1) NL159283B (nl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2104740A1 (nl) * 1970-03-17 1972-04-21 Merck & Co Inc

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3678149A (en) * 1970-01-26 1972-07-18 Samuel J Prigal Method of enhancing the action of a medicament
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
US4530832A (en) * 1978-12-07 1985-07-23 Schering Corporation Method of vaccination for prevention of Bordetella bronchiseptica infection
EP0059521B1 (en) * 1981-03-03 1985-01-02 Centraal Diergeneeskundig Instituut Water-in-oil emulsion for use in the potentation of the immune system of animals
FR2501526A1 (fr) * 1981-03-13 1982-09-17 Montagne Noire Produits Chimiq Nouveaux emulsionnants et leur application pour la production de vaccins
US4707470A (en) * 1985-05-17 1987-11-17 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
DE69229779T2 (de) * 1991-04-19 1999-12-23 Lds Technologies Inc Konvertierbare mikroemulsionsverbindungen
JP3609827B2 (ja) * 1991-06-26 2005-01-12 ヤマノウチ ユーロープ ベスローテン フェンノートシャップ 非極性基剤における小胞
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
ATE147619T1 (de) 1992-05-13 1997-02-15 Sandoz Ag Opthalmische zusammensetzungen enthaltend ein cyclosporin
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
WO1994008610A1 (en) * 1992-10-16 1994-04-28 Smithkline Beecham Corporation Pharmaceutical emulsion compositions
DK17093D0 (da) * 1993-02-15 1993-02-15 Lyfjathroun H F Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder
ATE218359T1 (de) 1994-11-03 2002-06-15 Novartis Erfind Verwalt Gmbh Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
SI0750907T1 (en) * 1995-06-30 2002-08-31 American Cyanamid Company Stable macrolide and macrolide vaccine compositions
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
US6245349B1 (en) 1996-02-23 2001-06-12 éLAN CORPORATION PLC Drug delivery compositions suitable for intravenous injection
AU728221B2 (en) 1996-06-05 2001-01-04 Ashmont Holdings Limited Injectable compositions
TR199901686T2 (xx) 1997-01-30 1999-09-21 Norvartis Ag Esasen ya�s�z farmakolojik kompozisyonlar� i�eren sert jelatin kaps�ller.
EP1023045A2 (en) * 1997-10-24 2000-08-02 Neorx Corporation Delivery vehicles for bioactive agents and uses thereof
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US8703095B2 (en) * 2005-07-07 2014-04-22 Sanofi Pasteur S.A. Immuno-adjuvant emulsion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE25721E (en) * 1965-01-26 Swine erysipelas vaccine
US2966443A (en) * 1959-06-22 1960-12-27 American Cyanamid Co Trivalent poliomyelitis live virus vaccine
US3099601A (en) * 1959-10-02 1963-07-30 Anchor Serum Company Bacterin in aqueous polyethylene, mineral oil emulsion
US3096249A (en) * 1960-05-10 1963-07-02 Samuel J Prigal Emulsion composition
GB914894A (en) * 1960-08-12 1963-01-09 Beecham Res Lab Injectable pharmaceutical media
US3149036A (en) * 1961-10-16 1964-09-15 Merck & Co Inc Adjuvant vaccine with aluminum monostearate, mannide monooleate, vegetable oil, and an aqueous phase immunolgical agent
US3185625A (en) * 1961-11-08 1965-05-25 Brown Ethan Allan Injectionable substances

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2104740A1 (nl) * 1970-03-17 1972-04-21 Merck & Co Inc

Also Published As

Publication number Publication date
BE699678A (nl) 1967-12-08
NL159283B (nl) 1979-02-15
FR7316M (nl) 1969-10-06
IT1035004B (it) 1979-10-20
GB1171125A (en) 1969-11-19
DE1617502A1 (de) 1972-02-10
US3384544A (en) 1968-05-21

Similar Documents

Publication Publication Date Title
AT281852B (nl)
AU5917865A (nl)
AU424443B2 (nl)
AU428063B2 (nl)
AU433222B2 (nl)
AU415165B1 (nl)
AU421822B2 (nl)
AU417216B2 (nl)
AU414526B2 (nl)
AU1144366A (nl)
AU5895065A (nl)
AU218666A (nl)
AU1111066A (nl)
AU612166A (nl)
AU6703465A (nl)
BE694653A (nl)
AU2390066A (nl)
AU414093B2 (nl)
BE694626A (nl)
BE674777A (nl)
BE693026A (nl)
BE682811A (nl)
BE680879A (nl)
AU6852465A (nl)
BE692888A (nl)

Legal Events

Date Code Title Description
VJC Lapsed due to non-payment of the due maintenance fee for the patent or patent application
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: GLAXO LAB